Journal of the American College of Cardiology

Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease?
pp. 1-8(8)
Authors: O'Keefe J.H.; Wetzel M.; Moe R.R.; Brosnahan K.; Lavie C.J.

Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion
pp. 9-18(10)
Authors: Roe M.T.; Ohman E.M.; Maas A.C.P.; Christenson R.H.; Mahaffey K.W.; Granger C.B.; Harrington R.A.; Califf R.M.; Krucoff M.W.

Non-Q-wave myocardial infarction following thrombolytic therapy: a comparison of outcomes in patients randomized to invasive or conservative post-infarct assessment strategies in the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial
pp. 19-25(7)
Authors: Wexler L.F.; Blaustein A.S.; Lavori P.W.; Lehmann K.G.; Wade M.; Boden W.E.; for the Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital VANQWISH Trial Investigators

Is ST segment elevation non-Q- wave myocardial infarction after thrombolytic therapy a new clinical entity that requires an invasive management strategy?*
pp. 26-29(4)
Authors: Chaitman B.R.; Bitar S.R.

Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetate
pp. 30-36(7)
Authors: Maes A.F.; Van de Werf F.; Mesotten L.V.; Flamen P.B.; Kuzo R.S.; Nuyts J.L.; Mortelmans L.

Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction¹
pp. 37-43(7)
Authors: Mehta S.R.; Eikelboom J.W.; Natarajan M.K.; Diaz R.; Yi C.; Gibbons R.J.; Yusuf S.

Course and prognostic implications of QT interval and QT interval variability after primary coronary angioplasty in acute myocardial infarction
pp. 44-50(7)
Authors: Bonnemeier H.; Hartmann F.; Wiegand U.K.H.; Bode F.; Katus H.A.; Richardt G.

Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results
pp. 51-58(8)
Authors: Rodriguez A.; Bernardi V.; Navia J.; Baldi J.; Grinfeld L.; Martinez J.; Vogel D.; Grinfeld R.; Delacasa A.; Garrido M.; Oliveri R.; Mele E.; Palacios I.; O'Neill W.; for the ERACI II Investigators

Present-day PTCR versus CABG: a randomized comparison with a different focus and a new result*
pp. 59-62(4)
Author: Ryan T.J.

Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study
pp. 63-69(7)
Authors: Nakamura M.; Nishikawa H.; Mukai S.; Setsuda M.; Nakajima K.; Tamada H.; Suzuki H.; Ohnishi T.; Kakuta Y.; Nakano T.; Yeung A.C.

Arterial remodeling influences the development of intimal hyperplasia after stent implantation
pp. 70-75(6)
Authors: Endo A.; Hirayama H.; Yoshida O.; Arakawa T.; Akima T.; Yamada T.; Nanasato M.

Angioplasty increases coronary sinus F₂-isoprostane formation: evidence for in vivo oxidative stress during PTCA
pp. 76-80(5)
Authors: Iuliano L.; Pratico D.; Greco C.; Mangieri E.; Scibilia G.; FitzGerald G.A.; Violi F.

No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management - A prospective, randomized comparison of patients with suspicion of jeopardized myocardium
pp. 81-88(8)
Authors: Siebelink H.-M.J.; Blanksma P.K.; Crijns H.J.G.M.; Bax J.J.; van Boven A.J.; Kingma T.; Piers D.A.; Pruim J.; Jager P.L.; Vaalburg W.; van der Wall E.E.

Testing our tests: surrogate end points versus driving patient management and outcomes*
pp. 89-92(4)
Author: Udelson J.E.

Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease
pp. 93-99(7)
Authors: Urano H.; Ikeda H.; Ueno T.; Matsumoto T.; Murohara T.; Imaizumi T.

Energy stores and metabolites in chronic reversibly and irreversibly dysfunctional myocardium in humans
pp. 100-108(9)
Authors: Wiggers H.; Noreng M.; Paulsen P.K.; Bottcher M.; Egeblad H.; Nielsen T.T.; Botker H.E.

Absolute quantitation of coronary steal induced by intravenous dipyridamole
pp. 109-116(8)
Authors: Akinboboye O.O.; Idris O.; Chou R.-L.; Sciacca R.R.; Cannon P.J.; Bergmann S.R.

N-acetylcysteine improves coronary and peripheral vascular function
pp. 117-123(7)
Authors: Andrews N.P.; Prasad A.; Quyyumi A.A.

Myocardial perfusion in patients with permanent ventricular pacing and normal coronary arteries
pp. 124-129(6)
Authors: Skalidis E.I.; Kochiadakis G.E.; Koukouraki S.I.; Chrysostomakis S.I.; Igoumenidis N.E.; Karkavitsas N.S.; Vardas P.E.

Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men
pp. 130-136(7)
Authors: Tadamura E.; Iida H.; Matsumoto K.; Mamede M.; Kubo S.; Toyoda H.; Shiozaki T.; Mukai T.; Magata Y.; Konishi J.

The physiological role of endogenous endothelin in the regulation of human coronary vasomotor tone
pp. 137-143(7)
Authors: MacCarthy P.A.; Pegge N.C.; Prendergast B.D.; Shah A.M.; Groves P.H.

When to stress patients after coronary artery bypass surgery? - Risk stratification in patients early and late post-CABG using stress myocardial perfusion SPECT: implications of apppropriate clinical strategies
pp. 144-152(9)
Authors: Zellweger M.J.; Lewin H.C.; Lai S.; Dubois E.A.; Friedman J.D.; Germano G.; Kang X.; Sharir T.; Berman D.S.

Age-predicted maximal heart rate revisited
pp. 153-156(4)
Authors: Tanaka H.; Monahan K.D.; Seals D.R.

Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion
pp. 157-162(6)
Authors: Lombardi F.; Colombo A.; Basilico B.; Ravaglia R.; Garbin M.; Vergani D.; Battezzati P.M.; Fiorentini C.

Should diastolic and systolic blood pressure be considered for cardiovascular risk evaluation: a study in middle-aged men and women
pp. 163-168(6)
Authors: Benetos A.; Thomas F.; Safar M.E.; Bean K.E.; Guize L.

Contrasting clinical properties and exercise responses in obese and lean hypertensive patients
pp. 169-174(6)
Authors: Weber M.A.; Neutel J.M.; Smith D.H.G.

Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans
pp. 175-182(8)
Authors: Schmieder R.E.; Erdmann J.; Delles C.; Jacobi J.; Fleck E.; Hilgers K.; Regitz-Zagrosek V.

Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure
pp. 183-188(6)
Authors: Ghio S.; Gavazzi A.; Campana C.; Inserra C.; Klersy C.; Sebastiani R.; Arbustini E.; Recusani F.; Tavazzi L.

Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine era
pp. 189-194(6)
Authors: John R.; Rajasinghe H.A.; Itescu S.; Suratwalla S.; Lietz K.; Weinberg A.D.; Kocher A.; Mancini D.M.; Drusin R.E.; Oz M.C.; Smith C.R.; Rose E.A.; Edwards N.M.

Heart failure etiology affects peripheral vascular endothelial function after cardiac transplantation
pp. 195-200(6)
Authors: Patel A.R.; Kuvin J.T.; Pandian N.G.; Smith J.J.; Udelson J.E.; Mendelsohn M.E.; Konstam M.A.; Karas R.H.

Left ventricular mechanics during and after acute rheumatic fever: contractile dysfunction is closely related to valve regurgitation
pp. 201-207(7)
Authors: Gentles T.L.; Colan S.D.; Wilson N.J.; Biosa R.; Neutze J.M.

Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy
pp. 208-214(7)
Authors: Flores-Ramirez R.; Lakkis N.M.; Middleton K.J.; Killip D.; Spencer W.H.; Nagueh S.F.

G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism
pp. 215-218(4)
Authors: Miles J.S.; Miletich J.P.; Goldhaber S.Z.; Hennekens C.H.; Ridker P.M.

Ambulatory norepinephrine treatment of severe autonomic orthostatic hypotension
pp. 219-223(5)
Authors: Oldenburg O.; Mitchell A.; Nurnberger J.; Koeppen S.; Erbel R.; Philipp T.; Kribben A.

Androgenic anabolic steroids and arterial structure and function in male bodybuilders
pp. 224-230(7)
Authors: Sader M.A.; Griffiths K.A.; McCredie R.J.; Handelsman D.J.; Celermajer D.S.

Inducibility of intra-atrial reentrant tachycardia after the first two stages of the Fontan sequence
pp. 231-237(7)
Authors: Law I.H.; Fischbach P.S.; Goldberg C.; Mosca R.S.; Bove E.L.; Lloyd T.R.; Rocchini A.P.; Dick M.

Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela
pp. 238-242(5)
Authors: Moak J.P.; Barron K.S.; Hougen T.J.; Wiles H.B.; Balaji S.; Sreeram N.; Cohen M.H.; Nordenberg A.; Van Hare G.F.; Friedman R.A.; Perez M.; Cecchin F.; Schneider D.S.; Nehgme R.A.; Buyon J.P.

Late rejection is a predictor of transplant coronary artery disease in children
pp. 243-250(8)
Authors: Mulla N.F.; Johnston J.K.; Vander Dussen L.; Beeson W.L.; Chinnock R.E.; Bailey L.L.; Larsen R.L.

Reconstruction of stenotic or occluded iliofemoral veins and inferior vena cava using intravascular stents: re-establishing access for future cardiac catheterization and cardiac surgery
pp. 251-257(7)
Authors: Ing F.F.; Fagan T.E.; Grifka R.G.; Clapp S.; Nihill M.R.; Cocalis M.; Perry J.; Mathewson J.; Mullins C.E.

The Amplatzer duct occluder: experience in 209 patients
pp. 258-261(4)
Authors: Bilkis A.A.; Alwi M.; Hasri S.; Haifa A.L.; Geetha K.; Rehman M.A.; Hasanah I.

Quantitative assessment of myocardial perfusion during graded coronary stenosis by real-time myocardial contrast echo refilling curves
pp. 262-269(8)
Authors: Masugata H.; Peters B.; Lafitte S.; Strachan G.M.; Ohmori K.; DeMaria A.N.

Improvement of afterload mismatch of left atrial booster pump function with positive inotropic agent
pp. 270-277(8)
Authors: Sakai H.; Kunichika H.; Murata K.; Seki K.; Katayama K.; Hiro T.; Miura T.; Matsuzaki M.

Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler
pp. 278-285(8)
Authors: Nagueh S.F.; Sun H.; Kopelen H.A.; Middleton K.J.; Khoury D.S.

Sildenafil citrate (Viagra) does not exacerbate myocardial ischemia in canine models of coronary artery stenosis
pp. 286-292(7)
Authors: Przyklenk K.; Kloner R.A.

Renin angiotensin system-dependent hypertrophy as a contributor to heart failure in hypertensive rats: different characteristics from renin angiotensin system-independent hypertrophy
pp. 293-299(7)
Authors: Sakata Y.; Masuyama T.; Yamamoto K.; Doi R.; Mano T.; Kuzuya T.; Miwa T.; Takeda H.; Hori M.

Beta-adrenoceptor stimulation attenuates the hypertrophic effect of alpha-adrenoceptor stimulation in adult rat ventricular cardiomyocytes
pp. 300-307(8)
Authors: Schafer M.; Ponicke K.; Heinroth-Hoffmann I.; Brodde O.-E.; Piper H.M.; Schluter K.-D.

Multiple endothelial injury in epicardial coronary artery induces downstream microvascular spasm as well as remodeling partly via thromboxane A₂
pp. 308-315(8)
Authors: Saitoh S.-i.; Onogi F.; Aikawa K.; Muto M.; Saito T.; Maehara K.; Maruyama Y.

Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemia
pp. 316-322(7)
Authors: Frolkis I.; Gurevitch J.; Yuhas Y.; Iaina A.; Wollman Y.; Chernichovski T.; Paz Y.; Matsa M.; Pevni D.; Kramer A.; Shapira I.; Mohr R.

Why did JACC reject my manuscript?
pp. 323-324(2)
Author: Parmley W.W.

President's page: enhancing the college's advocacy efforts
pp. 325-327(3)
Author: Beller G.A.

Color M-mode Doppler flow propagation velocity in cardiac tamponade
pp. 328-329(2)
Authors: Togni M.; Shabetai R.; Blanchard D.

Color M-mode Doppler flow propagation velocity in cardiac tamponade: Reply
pp. 329-329(1)
Author: Garcia M.J.

Apolipoprotein E genotype and coronary heart disease
pp. 329-330(2)
Authors: Batalla A.; Alvarez R.; Hevia S.; Reguero J.R.; Coto E.

Apolipoprotein E genotype and coronary heart disease: Reply
pp. 330-331(2)
Author: Akosah K.O.

Mild hypercholesterolemia and premature heart disease: Reply
pp. 331-332(2)
Authors: Nordestgaard B.G.; Frikke-Schmidt R.; Tybjaerg-Hansen A.

Mild hypercholesterolemia and premature heart disease
pp. 331-331(1)
Authors: Batalla A.; Reguero J.R.; Hevia S.; Cubero G.I.; Cortina A.

Dispersion of repolarization during induction and termination of ventricular fibrillation: Reply
pp. 332-333(2)
Author: Franz M.R.

Dispersion of repolarization during induction and termination of ventricular fibrillation
pp. 332-332(1)
Author: Erdogan O.

C-type natriuretic peptide and vascular remodeling
pp. 333-333(1)
Authors: Davidson N.C.; Struthers A.D.

C-type natriuretic peptide and vascular remodeling: Reply
pp. 333-334(2)
Authors: Shimokawa H.; Morishige K.; Takeshita A.

Stress testing and electron beam computed tomography for evaluation of patients with suspected coronary artery disease
pp. 334-335(2)
Author: Danias P.G.

Evaluating coronary artery disease-where does EBCT fit in?
pp. 335-336(2)
Authors: Sheppard R.; Eisenberg M.J.

Evaluating coronary artery disease-where does EBCT fit in?: Reply
pp. 336-337(2)
Authors: Shavelle D.M.; Budoff M.J.

Molecular effects of HMG-CoA reductase inhibitors on smooth muscle cell proliferation
pp. 337-338(2)
Authors: Skaletz-Rorowski A.; Eschert H.; Pawlus E.; Breithardt G.

Molecular effects of HMG-CoA reductase inhibitors on smooth muscle cell proliferation: Reply
pp. 338-338(1)
Authors: Indolfi C.; Torella D.; Chiariello M.

Corrections
pp. 339-339(1)

Mechanical cardiac support 2000: current applications and future trial design - June 15-16, 2000 Bethesda, Maryland
pp. 340-370(31)
Authors: Stevenson L.W.; Kormos R.L.